cholesterol

Novartis strikes landmark deal with NHS to speed up inclisiran access

https://pharmaphorum.com/news/novartis-strikes-landmark-deal-with-nhs-to-speed-up-inclisiran-access/

Amgen pulls higher-priced Repatha to try to lift sales

https://pharmaphorum.com/news/amgen-pulls-higher-priced-repatha-to-try-to-lift-sales/

TMC’s inclisiran impresses at ESC, but will it surpass PCSK9 rivals?

https://pharmaphorum.com/news/tmcs-inclisiran-impresses-at-esc-but-will-it-surpass-pcsk9-rivals/

TMC inches closer to inclisiran approval with long-term safety data

https://pharmaphorum.com/news/tmc-inches-closer-to-inclisiran-approval-with-long-term-safety-data/

Merck axes cholesterol drug despite phase 3 success

https://pharmaphorum.com/news/merck-axes-cholesterol-drug-despite-phase-3-success/

Merck & Co hit by GoldenEye ransomware

https://pharmaphorum.com/news/merck-co-hit-goldeneye-virus/

Court bans US sales of Sanofi cholesterol drug

https://pharmaphorum.com/news/court-bans-us-sales-sanofi-cholesterol-drug/

Pfizer’s hopes for cholesterol blockbuster dashed

https://pharmaphorum.com/news/pfizers-hopes-cholesterol-blockbuster-dashed/

Amgen’s cholesterol drug gets new monthly dose

https://pharmaphorum.com/news/amgens-cholesterol-drug-gets-new-monthly-dose/

Close in 10 seconds

Pharmaphorum.com

Search